Trials / Completed
CompletedNCT01330784
Assessment of the Therapeutic Utility of hMG-HP
Assessment of the Therapeutic Utility of hMG-HP Within a Protocol of Controlled Ovarian Hyperstimulation in IVF in Normoresponders Women Undergoing Downregulation With GnRH Antagonist
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 61 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of a protocol of ovarian hyperstimulation with urinary gonadotrophins, to achieve clinical pregnancy in females undergoing IVF. Study hypothesis: to assess the effectiveness of a protocol of urinary gonadotrophins
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | hMG-HP |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2008-07-01
- Completion
- 2008-09-01
- First posted
- 2011-04-07
- Last updated
- 2011-04-07
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01330784. Inclusion in this directory is not an endorsement.